Roszdravnadzor denied the message about a possible shortage of drugs for ARVI

& nbsp; Истoчник aif.ru At the same time, the list was replenished with the following names: human immunoglobulin against COVID-19, sarilumab, anakinra, netakimab, apixaban and others. Previously & nbsp ; in the Russian Federation, the list of drugs & nbsp; for the treatment of COVID-19 was updated. The decree was extended until January 1, 2024. The press service of Roszdravnadzor stated that there is no shortage of drugs for the treatment and prevention of COVID-19, influenza and ARVI in the regions, the Rossiyskaya Gazeta writes. Azithromycin and interferon beta-1b were excluded from the list of acceptable drugs. It is noted that due to seasonal demand, the production of many drugs has increased. The department stressed that complaints citizens did not report the lack of these drugs in pharmacies and Roszdravnadzor is constantly monitoring the availability of drugs in the regions.